BioCentury
ARTICLE | Financial News

OncoCyte financial update

October 12, 2015 7:00 AM UTC

OncoCyte Corp., Alameda, Calif. Business: Cancer, Gene/Cell therapy Date announced: 2015-10-07 Note: OncoCyte, a majority-owned subsidiary of BioTime Inc. (NYSE-M:BTX; Tel Aviv:BTX, Alameda, Calif.),...